Return On Equity of Grace Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Grace Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Grace Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -13%, a 34% increase year-over-year.
  • Grace Therapeutics, Inc. annual Return On Equity for 2024 was -15%, a 6.9% decline from 2023.
  • Grace Therapeutics, Inc. annual Return On Equity for 2023 was -14%, a 68% increase from 2022.
  • Grace Therapeutics, Inc. annual Return On Equity for 2022 was -44%, a 13% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Grace Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -13% +6.4% +34% 01 Jul 2025 30 Sep 2025
Q2 2025 -17% +0.83% +4.6% 01 Apr 2025 30 Jun 2025
Q1 2025 -16% +3.6% +18% 01 Jan 2025 31 Mar 2025
Q4 2024 -23% +36% +60% 01 Oct 2024 31 Dec 2024
Q3 2024 -19% +35% +65% 01 Jul 2024 30 Sep 2024
Q2 2024 -18% +33% +64% 01 Apr 2024 30 Jun 2024
Q1 2024 -20% +26% +57% 01 Jan 2024 31 Mar 2024
Q4 2023 -59% -42% -250% 01 Oct 2023 31 Dec 2023
Q3 2023 -55% -38% -237% 01 Jul 2023 30 Sep 2023
Q2 2023 -51% -41% -397% 01 Apr 2023 30 Jun 2023
Q1 2023 -46% -36% -353% 01 Jan 2023 31 Mar 2023
Q4 2022 -17% -3% -22% 01 Oct 2022 31 Dec 2022
Q3 2022 -16% +1.5% +8.5% 01 Jul 2022 30 Sep 2022
Q2 2022 -10% +40% +80% 01 Apr 2022 30 Jun 2022
Q1 2022 -10% +68% +87% 01 Jan 2022 31 Mar 2022
Q4 2021 -14% +256% +95% 01 Oct 2021 31 Dec 2021
Q3 2021 -18% +660% +97% 01 Jul 2021 30 Sep 2021
Q2 2021 -50% +1287% +96% 01 Apr 2021 30 Jun 2021
Q1 2021 -78% +2334% +97% 01 Jan 2021 31 Mar 2021
Q4 2020 -270% +3246% +92% 01 Oct 2020 31 Dec 2020
Q3 2020 -677% 01 Jul 2020 30 Sep 2020
Q2 2020 -1337% 01 Apr 2020 30 Jun 2020
Q1 2020 -2411% 01 Jan 2020 31 Mar 2020
Q4 2019 -3516% 01 Oct 2019 31 Dec 2019

Grace Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -15% -0.96% -6.9% 01 Apr 2024 31 Mar 2025
2023 -14% +30% +68% 01 Apr 2023 31 Mar 2024
2022 -44% -5.1% -13% 01 Apr 2022 31 Mar 2023
2021 -39% +663% +94% 01 Apr 2021 31 Mar 2022
2020 -702% 01 Apr 2020 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.